| Product Code: ETC13309925 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Endocrine Testing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Endocrine Testing Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Endocrine Testing Market Revenues & Volume, 2021 & 2031F |
3.3 North America Endocrine Testing Market - Industry Life Cycle |
3.4 North America Endocrine Testing Market - Porter's Five Forces |
3.5 North America Endocrine Testing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Endocrine Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 North America Endocrine Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 North America Endocrine Testing Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 North America Endocrine Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Endocrine Testing Market Trends |
6 North America Endocrine Testing Market, 2021 - 2031 |
6.1 North America Endocrine Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Endocrine Testing Market, Revenues & Volume, By Estradiol (E2) Test, 2021 - 2031 |
6.1.3 North America Endocrine Testing Market, Revenues & Volume, By Follicle Stimulating Hormone (FSH) Test, 2021 - 2031 |
6.1.4 North America Endocrine Testing Market, Revenues & Volume, By Human Chorionic Gonadotropin (hCG) Hormone Test, 2021 - 2031 |
6.1.5 North America Endocrine Testing Market, Revenues & Volume, By Luteinizing Hormone (LH) Test, 2020 - 2028 |
6.1.6 North America Endocrine Testing Market, Revenues & Volume, By Dehydroepiandrosterone Sulfate (DHEAS) Test, 2020 - 2028 |
6.1.7 North America Endocrine Testing Market, Revenues & Volume, By Progesterone Test, 2020 - 2028 |
6.1.8 North America Endocrine Testing Market, Revenues & Volume, By Testosterone Test, 2020 - 2028 |
6.1.9 North America Endocrine Testing Market, Revenues & Volume, By Others, 2020 - 2028 |
6.2 North America Endocrine Testing Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Endocrine Testing Market, Revenues & Volume, By Tandem Mass Spectrometry, 2021 - 2031 |
6.2.3 North America Endocrine Testing Market, Revenues & Volume, By Immunoassay, 2021 - 2031 |
6.2.4 North America Endocrine Testing Market, Revenues & Volume, By Monoclonal & Polyclonal Antibody Technologies, 2021 - 2031 |
6.2.5 North America Endocrine Testing Market, Revenues & Volume, By Sensor Technology, 2021 - 2031 |
6.2.6 North America Endocrine Testing Market, Revenues & Volume, By Clinical Chemistry, 2020 - 2028 |
6.2.7 North America Endocrine Testing Market, Revenues & Volume, By Others, 2020 - 2028 |
6.3 North America Endocrine Testing Market, Revenues & Volume, By End use, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Endocrine Testing Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 North America Endocrine Testing Market, Revenues & Volume, By Commercial Laboratories, 2021 - 2031 |
6.3.4 North America Endocrine Testing Market, Revenues & Volume, By Ambulatory Care Centers, 2021 - 2031 |
6.3.5 North America Endocrine Testing Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Endocrine Testing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Endocrine Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 United States (US) Endocrine Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Canada Endocrine Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 Rest of North America Endocrine Testing Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 North America Endocrine Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
7.3.1 United States (US) Endocrine Testing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.2 Canada Endocrine Testing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.3 Rest of North America Endocrine Testing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4 North America Endocrine Testing Market, Revenues & Volume, By End use, 2021 - 2031 |
7.4.1 United States (US) Endocrine Testing Market, Revenues & Volume, By End use, 2021 - 2031 |
7.4.2 Canada Endocrine Testing Market, Revenues & Volume, By End use, 2021 - 2031 |
7.4.3 Rest of North America Endocrine Testing Market, Revenues & Volume, By End use, 2021 - 2031 |
8 North America Endocrine Testing Market Key Performance Indicators |
9 North America Endocrine Testing Market - Export/Import By Countries Assessment |
10 North America Endocrine Testing Market - Opportunity Assessment |
10.1 North America Endocrine Testing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Endocrine Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 North America Endocrine Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.4 North America Endocrine Testing Market Opportunity Assessment, By End use, 2021 & 2031F |
11 North America Endocrine Testing Market - Competitive Landscape |
11.1 North America Endocrine Testing Market Revenue Share, By Companies, 2022 |
11.2 North America Endocrine Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here